NEFL and amyotrophic lateral sclerosis: Moreover, BEV-associated biomarkers such as neurofilament light chain (NfL) and phosphorylated TDP-43 have demonstrated superior performance over their plasma counterparts in staging and tracking progression in ALS [29].